Search Results
Trump Administration Finalizes Policies to Advance Rural Health and Medical Innovation
Historic changes to the Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital (LTCH) Prospective Payment System mean better quality and access
Press releaseSpeech: Remarks by Administrator Seema Verma at the Financial Times Pharma Pricing and Value Summit
Remarks by Administrator Seema Verma at the Financial Times Pharma Pricing and Value Summit (As prepared for delivery – September 13, 2018)
Press releaseCMS Finalizes Changes to Empower Patients and Reduce Administrative Burden
Changes in the Inpatient Prospective Payment System and Long-Term Care Hospital Prospective Payment System final rule will advance price transparency and electronic health records.
Press releaseMedicare Part D premiums continue to decline in 2019
Today, the Centers for Medicare & Medicaid Services (CMS) announced that, for the second year in a row, the average basic premium for a Medicare Part D prescription drug plan in 2019 is projected to decline.
Press releaseSpeech: Medicare Remarks by CMS Administrator Seema Verma at the Commonwealth Club of California
I’d like to talk to you about things on which we all agree, like the future of our healthcare system, and Medicare. And if we have time we can touch quickly on world peace before we all leave.
Press releaseCMS Empowers Patients and Ensures Site-Neutral Payment in Proposed Rule
Outpatient Prospective Payment System (OPPS) & Ambulatory Surgical Center (ASC) proposed rule advances CMS commitment to increasing transparency and lowering drug prices.
Press releaseCMS Adopts the Methodology for the Permanent Risk Adjustment Program under the Patient Protection and Affordable Care Act for the 2017 Benefit Year
Final rule addresses the collection of risk adjustment charges and making of payments for the 2017 benefit year.
Press releaseCMS Welcomes New Leadership Team, Makes Additional Staffing Announcement
Today, the Centers for Medicare & Medicaid Services (CMS) announced several new additions to the agency’s leadership team, as well as changes to the portfolios of senior staff in the Office of the Administrator.
Press releaseAdministrator Verma Statement on FDA’s Biosimilars Action Plan
CMS and FDA are both working to accelerate innovation in the biosimilars market – CMS has taken action to do so by providing biosimilars with separate payment codes and by lowering the amount of cost sharing that low-income beneficiaries pay for biosimilars.
Press release